Addiction of Drugs: An Overview

Giovanni Abbruzzese^*
*Correspondence: Giovanni Abbruzzese, Department of Neurorehabiliation, University of Genoa, Genoa, Italy, Email:

Editorial

Drug addiction, also known as substance dependence or dependent syndrome, is a psychological disorder in which a person has a strong desire to use a substance. Addiction encompasses a wide range of behaviours [1]. These include finding it difficult to resist the urge to use the substance and believing that it is more essential than more mundane things like family or work [2-4]. When a person stops using the medicine for an extended period of time, they may experience withdrawal symptoms. Drug addiction, also known as substance use disorder, is an illness that affects a person's brain and behaviour, resulting in an inability to manage the use of any drug or prescription, legal or illicit. Drugs include alcoholic beverages, marijuana, and nicotine. You may continue to use the substance despite the harm it causes if you are addicted [5-7].

Drug addiction can be classified into several phases. At the initial stage, when a person is simply seeking new pleasure out of curiosity, he is assured that he will be able to get through it without difficulty. The individual becomes accustomed to consuming drugs at parties or in the company of friends in the second stage. The guy becomes a victim of his habit in the third stage. His body will display signs if he does not take it at regular intervals. Heroin, for example, belongs to the opiate class of drugs. Which means that someone who is addicted to Heroin may also be hooked to other opiates like Morphine? [7-9]

A person with an addictive personality is someone who is prone to being addicted to substances. Drug addiction is classified as a mental disease by the Diagnostic and Statistical Manual of Mental Disorders. Addiction to drugs is frequently associated with other mental illnesses [10].

Drug addiction symptoms

• Ignoring duties at school, job, or home in order to pursue a substance.

• Having strong desires or irritability when you aren't utilising drugs.

• Using drugs despite the potential negative effects on relationships, jobs, finances, and physical and mental health.

• Using the substance while knowing that it is giving you troubles in your life or causing you physical or psychological harm.

• Doing things you wouldn't ordinarily do to obtain the substance, like as stealing.

• Driving or engaging in other potentially dangerous activities while under the influence of the substance.

• Investing a significant amount of time on obtaining the drug, using the drug, or recuperating from the drug's side effects.

• Attempts to quit using the medicine have failed.

References

1. Abood, Mary E., and Billy R. Martin. "Neurobiology of marijuana abuse." Trends Pharmacol Sci 13 (1992): 201–206.   

Google Scholar, Crossref, Indexed at

2. Aceto, Mario D., Susan M. Scates, John A. Lowe, and Billy R. Martin. "Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal."  J Pharmacol Exp Ther 278 (1996): 1290–1295.

Google Scholar, Indexed at

3. Aceto, Mario D., Susan M. Scates, John A. Lowe, and Billy R. Martin. "Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A." Eur J Pharmacol 282 (1995): R1–R2.

Google Scholar, Crossref, Indexed at

4. Aceto, Mario D., Susan M. Scates, Raj K. Razdan, and Billy R. Martin. "Anandamide, an endogenous cannabinoid, has a very low physical dependence potential."  J Pharmacol Exp Ther 287 (1998): 598–605.

Google Scholar, Indexed at

5. Acquas, Elio, Ezio Carboni, and Gaetano Di Chiara. "Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats." Eur J Pharmacol  193 (1991):133–134.

Google Scholar, Crossref, Indexed at

6. Agurell, Stig, M. A. G. N. U. S. Halldin, J. E. Lindgren, A. G. N. E. T. A. Ohlsson, M. A. R. I. A. N. N. E. Widman, H. A. M. P. Gillespie, and L. Hollister. "Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man." Pharmacol Rev 38 (1986): 21–43.

Google Scholar, Indexed at

7. Alici, Tevfik, and James B. Appel. "Increasing the selectivity of the discriminative stimulus effects of Δ9-tetrahydrocannabinol: complete substitution with methanandamide." Pharmacol Biochem Behav 79 (2004): 431–437.

Google Scholar, Crossref

8. Bell, Carl C. "DSM-IV: diagnostic and statistical manual of mental disorders." Jama 10 (1994): 828-829.

Google Scholar, Crossref

9. Anggadiredja, Kusnandar, Masanori, Nakamichi, Takato, Hiranita, and Hiroyuki Tanaka, et al. "Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade." Neuropsychopharmacol 29 (2004): 1470–1478.

Google Scholar, Crossref, Indexed at

10. Arnold, Jennifer M., and David CS Roberts. "A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement." Pharmacol Biochem Behav 57 (1997): 441–447.

Google Scholar, Crossref, Indexed at